SCHEMBL6667774

SCHEMBL6667774

CN(Cc1ccc(Cl)cc1)C(=O)c1n[nH]c2ccc(CN3CCOCC3)cc2c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 6/20 0.46
JAK2 O60674 2/20 0.46
AKR1C3 P42330 1/20 0.43
NR1H4 Q96RI1 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
CDK7 P50613 3/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
LSS P48449 1/20 0.40
GSK3B P49841 2/20 0.40
DYRK1A Q13627 1/20 0.40
KCNH2 Q12809 1/20 0.40
MCHR1 Q99705 1/20 0.39
PDE1B Q01064 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7007040 0.87 PDE1B (0.45) CHEK1JAK2AKR1C3NR1H4NPC1
SCHEMBL6667754 0.83 AKR1C3 (0.39) CHEK1AKR1C3NR1H4HSP90AA1HSP90AB1
SCHEMBL6673044 0.83 ALDH1A1 (0.61) JAK2AKR1C3KDM4EALDH1A1GLA
SCHEMBL6672697 0.83 JAK2 (0.40) CHEK1JAK2AKR1C3KDM4EGAA
SCHEMBL7483549 0.83 HSP90AA1 (0.44) NR1H4ALDH1A1GAAHSP90AA1NPC1
SCHEMBL6670245 0.82 FLT3 (0.40) CHEK1JAK2AKR1C3KDM4EALDH1A1
SCHEMBL6667470 0.82 INSR (0.39) AKR1C3NR1H4NPC1RAB9ALSS
SCHEMBL7478855 0.82 POLA1 (0.39) CHEK1AKR1C3NR1H4NPC1RAB9A
SCHEMBL6672201 0.82 JAK2 (0.39) CHEK1JAK2AKR1C3KDM4EALDH1A1
SCHEMBL7472513 0.81 AKR1C3 (0.36) CHEK1AKR1C3NR1H4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004019940-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO claimed